MAPT and tauopathy: We have previously shown that acute anti-tau antibody treatment clears pathological tau and improves cognition, and targeting phosphorylated tau reverses functional abnormalities in layer 2/3 (L2/3) pyramidal neurons in the cortex of JNPL3 tauopathy mice,12–15 but targeting truncated tau for therapeutic clearance has not been well examined.